On Tuesday, ARS Pharmaceuticals Inc. SPRY announced a leadership transition. Co-founder and CEO Richard Lowenthal stepped ...
The biotechnology company said it was confident Casale would help grow the neffy franchise and position the company for near- and long-term value creation. Casale has more than 25 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On Friday, the FDA approved ARS Pharmaceuticals Inc’s (NASDAQ:SPRY) neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results